| Name | Title | Contact Details |
|---|
At Healthify, we build the infrastructure to support end-to-end care coordination across our social service networks.
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
TechHealth is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Arbor Company is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Universal Endoscopic Svc Inc is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.